TMT & Consumer Independent Equity Research Analyst, Obex Capital Research

Aaron Gabin

I have over 20 years’ experience investing in the TMT and Consumer sectors, almost entirely on the buyside. Started at Bernstein covering software in 2001, moved to the buyside at Government of Singapore Investment Corporation (GIC) in 2003, covering hardware, software, and media. 

After getting an MBA at NYU in 2008 and a CFA, I spent 8 years at Coburn Ventures (a market neutral TMT/Consumer hedge fund). In 2015, I joined Deimos Asset Management, a low net multi-strat, where I managed a  TMT/Consumer portfolio.

I've spent the past few years at Obex Capital Management providing independent investment research to TMT and Consumer investors.

TMT & Consumer Independent Equity Research Analyst

Match Group Buys Hyperconnect for $1.7 Billion

Match 1Q21 Earnings: Looking for an Opening

TMT & Consumer Independent Equity Research

Obex Capital Research

“Obex” is Latin for Barriers to Entry. Obex Capital Management’s investment philosophy is driven by an intense focus on which business model’s Barriers to Entry are able to withstand the ever increasing competitive disruption in the TMT and Consumer Sectors.

Equity Bottom-Up

<p>Post 3Q20, we closed out our note saying, “We think COVID will result in more headwinds then tailwinds, which will provide a headwind to guidance, and what we think will be an entry point come February when 2021 guidance is given. By then we will be 3 months closer to vaccines and 3 months closer to last years’ Q2 which was horrendous due to the initial restrictions and gives a great setup for an explosive 2Q21 quarter.”</p><p>Match  pulled back 8% on earnings and is down 11% in two weeks. At 36x forward EV/EBITDA, we are at the same valuation Match was after 2Q and 3Q…except we are now one quarter away from entering a period of accelerating EBITDA growth. Guidance does not contemplate a full return to “normal” by the back half of 2021…which means guidance is likely too conservative. Entry points on one of the great business models in TMT are few and far between. Its time to buy Match.</p><div class="content-highlight"><p>Obex’s fundamental research process is focused on secular change in the TMT and Consumer sectors. We seek to differentiate between fundamental business analysis and security analysis. Before deciding if a security’s pricing and positioning merit a long or short position, we analyze the four pillars of business fundamentals (Secular Factors, TAM, Competitive Advantage, Business Model) in order to determine if this is a “good” or “not so good” opportunity.</p></div>

Post 3Q20, we closed out our note saying, “We think COVID will result in more headwinds then tailwinds, which will provide a headwind to guidance, and what we think will be an entry point come February when 2021 guidance is given. By then we will be 3 months closer to vaccines and 3 months closer to last years’ Q2 which was horrendous due to the initial restrictions and gives a great setup for an explosive 2Q21 quarter.”Match  pulled back 8% on earnings and is down 11% in two weeks. At 36x forward EV/EBITDA, we are at the same valuation Match was after 2Q and 3Q…except we are now one quarter away from entering a period of accelerating EBITDA growth. Guidance does not contemplate a full return to “normal” by the back half of 2021…which means guidance is likely too conservative. Entry points on one of the great business models in TMT are few and far between. Its time to buy Match.Obex’s fundamental research process is focused on secular change in the TMT and Consumer sectors. We seek to differentiate between fundamental business analysis and security analysis. Before deciding if a security’s pricing and positioning merit a long or short position, we analyze the four pillars of business fundamentals (Secular Factors, TAM, Competitive Advantage, Business Model) in order to determine if this is a “good” or “not so good” opportunity.

Match Group

Match 4Q20 Earnings: Hook It Up